{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:41:41Z","timestamp":1792291301843,"version":"4.4.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/ncpendmet0142","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:34:49Z","timestamp":1147797289000},"page":"269-281","source":"Crossref","is-referenced-by-count":131,"title":["Diabetic neuropathies: clinical manifestations and current treatment options"],"prefix":"10.1038","volume":"2","author":[{"given":"Aaron","family":"Vinik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdeesh","family":"Ullal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri K","family":"Parson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina M","family":"Casellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0142_CR1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJM199409293311307","volume":"331","author":"GM Caputo","year":"1994","unstructured":"Caputo GM et al. (1994) Assessment and management of foot disease in patients with diabetes. N Engl J Med 331: 854\u2013860","journal-title":"N Engl J Med"},{"key":"BFncpendmet0142_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/dia.2005.7.497","volume":"7","author":"E Vinik","year":"2005","unstructured":"Vinik E et al. (2005) The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7: 497\u2013508","journal-title":"Diabetes Technol Ther"},{"issue":"3 Suppl","key":"BFncpendmet0142_CR3","first-page":"13","volume":"6","author":"AI Vinik","year":"2004","unstructured":"Vinik AI (2004) Advances in diabetes for the millennium: new treatments for diabetic neuropathies. MedGenMed 6 (3 Suppl): 13","journal-title":"MedGenMed"},{"key":"BFncpendmet0142_CR4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","volume":"27","author":"A Boulton","year":"2004","unstructured":"Boulton A et al. (2004) Diabetic somatic neuropathies. Diabetes Care 27: 1458\u20131486","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR5","first-page":"170","volume-title":"Textbook of Diabetic Neuropathy","author":"PJ Dyck","year":"2003","unstructured":"Dyck PJ (2003) Severity and staging of diabetic polyneuropathy. In Textbook of Diabetic Neuropathy, 170\u2013175 (Eds Gries FA et al.) Stuttgart: Thieme"},{"issue":"Suppl 2","key":"BFncpendmet0142_CR6","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","volume":"46","author":"PK Thomas","year":"1997","unstructured":"Thomas PK (1997) Classification, differential diagnosis and staging of diabetic peripheral neuropathy. Diabetes 46 (Suppl 2): S54\u2013S57","journal-title":"Diabetes"},{"key":"BFncpendmet0142_CR7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ et al. (2005) Position statement: diabetic neuropathies. Diabetes Care 28: 956\u2013962","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.mcna.2004.04.009","volume":"88","author":"A Vinik","year":"2004","unstructured":"Vinik A and Mehrabyan A (2004) Diabetic neuropathies. Med Clin North Am 88: 947\u2013999","journal-title":"Med Clin North Am"},{"key":"BFncpendmet0142_CR9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1464-5491.2002.00801.x","volume":"19","author":"SO Oyibo","year":"2002","unstructured":"Oyibo SO et al. (2002) The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19: 870\u2013873","journal-title":"Diabet Med"},{"key":"BFncpendmet0142_CR10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00418349","volume":"39","author":"S Tesfaye","year":"1996","unstructured":"Tesfaye S et al. (1996) Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycemic control (insulin neuritis). Diabetologia 39: 329\u2013335","journal-title":"Diabetologia"},{"key":"BFncpendmet0142_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.nrl.0000156314.24508.ed","volume":"11","author":"M Sinnreich","year":"2005","unstructured":"Sinnreich M et al. (2005) Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 11: 63\u201379","journal-title":"Neurologist"},{"key":"BFncpendmet0142_CR12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/diacare.16.11.1446","volume":"16","author":"M Harris","year":"1993","unstructured":"Harris M et al. (1993) Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 16: 1446\u20131452","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mus.1136","volume":"24","author":"JR Singleton","year":"2001","unstructured":"Singleton JR et al. (2001) Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24: 1225\u20131228","journal-title":"Muscle Nerve"},{"key":"BFncpendmet0142_CR14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.24.8.1448","volume":"24","author":"JR Singleton","year":"2001","unstructured":"Singleton JR et al. (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24: 1448\u20131453","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","volume":"60","author":"C Sumner","year":"2003","unstructured":"Sumner C et al. (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108\u2013111","journal-title":"Neurology"},{"issue":"Suppl 1","key":"BFncpendmet0142_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0021-9290(93)90077-R","volume":"26","author":"PR Cavanagh","year":"1993","unstructured":"Cavanagh PR et al. (1993) Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomech 26 (Suppl 1): 23\u201340","journal-title":"J Biomech"},{"key":"BFncpendmet0142_CR17","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/diacare.20.12.1904","volume":"20","author":"EC Katoulis","year":"1997","unstructured":"Katoulis EC et al. (1997) Gait abnormalities in diabetic neuropathy. Diabetes Care 20: 1904\u20131907","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","volume":"43","author":"PJ Dyck","year":"1993","unstructured":"Dyck PJ et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817\u2013824","journal-title":"Neurology"},{"key":"BFncpendmet0142_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880110106","volume":"11","author":"PJ Dyck","year":"1988","unstructured":"Dyck PJ (1988) Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21\u201332","journal-title":"Muscle Nerve"},{"key":"BFncpendmet0142_CR20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mus.880180603","volume":"18","author":"AI Vinik","year":"1995","unstructured":"Vinik AI et al. (1995) Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18: 574\u2013584","journal-title":"Muscle Nerve"},{"key":"BFncpendmet0142_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","volume":"19","author":"CA Abbott","year":"2002","unstructured":"Abbott CA et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377\u2013384","journal-title":"Diabet Med"},{"issue":"Suppl 2","key":"BFncpendmet0142_CR22","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diab.46.2.S5","volume":"46","author":"PJ Dyck","year":"1997","unstructured":"Dyck PJ et al. (1997) Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes 46 (Suppl 2): S5\u2013S8","journal-title":"Diabetes"},{"key":"BFncpendmet0142_CR23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(94)90239-9","volume":"125","author":"D Yarnitsky","year":"1994","unstructured":"Yarnitsky D and Sprecher E (1994) Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 125: 39\u201345","journal-title":"J Neurol Sci"},{"key":"BFncpendmet0142_CR24","doi-asserted-by":"crossref","unstructured":"Anonymous (1988) Consensus Statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 11: 592\u2013597","DOI":"10.2337\/diacare.11.7.592"},{"key":"BFncpendmet0142_CR25","doi-asserted-by":"crossref","unstructured":"Anonymous (1995) Peripheral Nerve Society. Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 38: 478\u2013482","DOI":"10.1002\/ana.410380323"},{"key":"BFncpendmet0142_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","volume":"333","author":"J Partanen","year":"1995","unstructured":"Partanen J et al. (1995) Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 89\u201394","journal-title":"N Engl J Med"},{"key":"BFncpendmet0142_CR27","doi-asserted-by":"crossref","unstructured":"DCCT Research Group (1995) The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561\u2013568","DOI":"10.7326\/0003-4819-122-8-199504150-00001"},{"key":"BFncpendmet0142_CR28","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/diacare.27.7.1783","volume":"27","author":"A Vinik","year":"2004","unstructured":"Vinik A et al. (2004) Focal entrapment neuropathies in diabetes. Diabetes Care 27: 1783\u20131788","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.47.4.1042","volume":"47","author":"WR Kennedy","year":"1996","unstructured":"Kennedy WR et al. (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042\u20131048","journal-title":"Neurology"},{"key":"BFncpendmet0142_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/152091501750219994","volume":"3","author":"M Polydefkis","year":"2001","unstructured":"Polydefkis M et al. (2001) Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 3: 23\u201328","journal-title":"Diabetes Technol Ther"},{"key":"BFncpendmet0142_CR31","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2337\/diacare.27.8.1974","volume":"27","author":"G Pittenger","year":"2004","unstructured":"Pittenger G et al. (2004) Intraepidermal nerve fibers are indicators of small fiber neuropathy in both diabetic and non-diabetic patients. Diabetes Care 27: 1974\u20131979","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR32","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/diacare.26.9.2549","volume":"26","author":"L Vileikyte","year":"2003","unstructured":"Vileikyte L et al. (2003) The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 26: 2549\u20132555","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR33","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","volume":"26","author":"RE Maser","year":"2003","unstructured":"Maser RE et al. (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26: 1895\u20131901","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1056-8727(92)90049-Q","volume":"6","author":"D Ziegler","year":"1992","unstructured":"Ziegler D et al. (1992) The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 6: 49\u201357","journal-title":"J Diabetes Complications"},{"key":"BFncpendmet0142_CR35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI et al. (2003) Diabetic autonomic neuropathy. Diabetes Care 26: 1553\u20131579","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"BFncpendmet0142_CR36","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/diab.46.2.S62","volume":"46","author":"D Ziegler","year":"1997","unstructured":"Ziegler D and Gries FA (1997) \u03b1-Lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46 (Suppl 2): S62\u2013S66","journal-title":"Diabetes"},{"key":"BFncpendmet0142_CR37","first-page":"201","volume":"53","author":"VG Athyros","year":"1998","unstructured":"Athyros VG et al. (1998) Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol 53: 201\u2013209","journal-title":"Acta Cardiol"},{"key":"BFncpendmet0142_CR38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","volume":"353","author":"P Gaede","year":"1999","unstructured":"Gaede P et al. (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized study. Lancet 353: 617\u2013622","journal-title":"Lancet"},{"key":"BFncpendmet0142_CR39","first-page":"481","volume-title":"Diabetic Neuropathy","author":"AJ Wilbourn","year":"1999","unstructured":"Wilbourn AJ (1999) Diabetic entrapment and compression neuropathies. In Diabetic Neuropathy, 481\u2013508 (Eds Dyck PJ and Thomas PK) Philadelphia: Saunders"},{"key":"BFncpendmet0142_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0168-8227(90)90077-7","volume":"10","author":"K Watanabe","year":"1990","unstructured":"Watanabe K et al. (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10: 19\u201327","journal-title":"Diabetes Res Clin Pract"},{"key":"BFncpendmet0142_CR41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/diacare.25.3.565","volume":"25","author":"B Perkins","year":"2002","unstructured":"Perkins B et al. (2002) Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 25: 565\u2013569","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","volume":"25","author":"PJ Dyck","year":"2002","unstructured":"Dyck PJ and Windebank AJ (2002) Diabetic and nondiabetic lumbosacral radiculoplexus neuropathy: new insights into pathophysiology and treatment. Muscle Nerve 25: 477\u2013491","journal-title":"Muscle Nerve"},{"key":"BFncpendmet0142_CR43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.59.5.758","volume":"59","author":"K Sharma","year":"2002","unstructured":"Sharma K et al. (2002) Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59: 758\u2013765","journal-title":"Arch Neurol"},{"key":"BFncpendmet0142_CR44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0733-8619(05)70358-3","volume":"15","author":"DA Krendel","year":"1997","unstructured":"Krendel DA et al. (1997) Autoimmune diabetic neuropathy. Neurol Clin 15: 959\u2013971","journal-title":"Neurol Clin"},{"key":"BFncpendmet0142_CR45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11892-004-0048-y","volume":"4","author":"DR Ayyar","year":"2004","unstructured":"Ayyar DR and Sharma KR (2004) Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Curr Diab Rep 4: 409\u2013412","journal-title":"Curr Diab Rep"},{"key":"BFncpendmet0142_CR46","doi-asserted-by":"crossref","unstructured":"DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977\u2013986","DOI":"10.1056\/NEJM199309303291401"},{"key":"BFncpendmet0142_CR47","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703\u2013713","DOI":"10.1136\/bmj.317.7160.703"},{"key":"BFncpendmet0142_CR48","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854\u2013865","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"BFncpendmet0142_CR49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383\u2013393","journal-title":"N Engl J Med"},{"key":"BFncpendmet0142_CR50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S et al. (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341\u2013350","journal-title":"N Engl J Med"},{"key":"BFncpendmet0142_CR51","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/diacare.27.9.2178","volume":"27","author":"D Ziegler","year":"2004","unstructured":"Ziegler D et al. (2004) Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 27: 2178\u20132183","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/er.2003-0019","volume":"25","author":"AM Vincent","year":"2004","unstructured":"Vincent AM et al. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25: 612\u2013628","journal-title":"Endocr Rev"},{"key":"BFncpendmet0142_CR53","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/diacare.27.10.2369","volume":"27","author":"V Bril","year":"2004","unstructured":"Bril V and Buchanan RA (2004) Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy. Diabetes Care 27: 2369\u20132375","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diacare.16.1.8","volume":"16","author":"H Keen","year":"1993","unstructured":"Keen H et al. (1993) Treatment of diabetic neuropathy with \u03b3-linolenic acid. The \u03b3-Linolenic Acid Multicenter Trial Group. Diabetes Care 16: 8\u201315","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","volume":"21","author":"D Ziegler","year":"2004","unstructured":"Ziegler D et al. (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant \u03b1-lipoic acid: a meta-analysis. Diabet Med 21: 114\u2013121","journal-title":"Diabet Med"},{"key":"BFncpendmet0142_CR56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mus.20423","volume":"32","author":"A Vinik","year":"2005","unstructured":"Vinik A et al. (2005) Sural sensory nerve action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve 32: 619\u2013625","journal-title":"Muscle Nerve"},{"key":"BFncpendmet0142_CR57","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.clinthera.2005.08.001","volume":"27","author":"A Vinik","year":"2005","unstructured":"Vinik A et al. (2005) Treatment of symptomatic diabetic peripheral neuropathy with protein kinase CB inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther 27: 1164\u20131180","journal-title":"Clin Ther"},{"key":"BFncpendmet0142_CR58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/EDR.2003.271","volume":"4","author":"G Pittenger","year":"2003","unstructured":"Pittenger G and Vinik A (2003) Nerve growth factor and diabetic neuropathy Exp Diabesity Res 4: 271\u2013285","journal-title":"Exp Diabesity Res"},{"key":"BFncpendmet0142_CR59","first-page":"0232:A54","volume-title":"National Diabetes Association, 59th Scientific Sessions: 1999, June 19\u201322; San Diego, CA","author":"AI Vinik","year":"1999","unstructured":"Vinik AI (1999) Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF). In National Diabetes Association, 59th Scientific Sessions: 1999, June 19\u201322; San Diego, CA, 48: 0232:A54"},{"key":"BFncpendmet0142_CR60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9440(10)65282-0","volume":"154","author":"A Rivard","year":"1999","unstructured":"Rivard A et al. (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154: 355\u2013363","journal-title":"Am J Pathol"},{"key":"BFncpendmet0142_CR61","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s001250050834","volume":"40","author":"Z Milicevic","year":"1997","unstructured":"Milicevic Z et al. (1997) Anti-ganglioside GM1 antibody and distal symmetric \u201cdiabetic polyneuropathy\u201d with dominant motor features. Diabetologia 40: 1364\u20131365","journal-title":"Diabetologia"},{"key":"BFncpendmet0142_CR62","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/diacare.28.8.2067","volume":"28","author":"AI Vinik","year":"2005","unstructured":"Vinik AI et al. (2005) Antibodies to neuronal structures: innocent bystanders or neurotoxins? Diabetes Care 28: 2067\u20132072","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR63","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2337\/diacare.28.8.1959","volume":"28","author":"V Granberg","year":"2005","unstructured":"Granberg V et al. (2005) Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care 28: 1959\u20131964","journal-title":"Diabetes Care"},{"key":"BFncpendmet0142_CR64","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1995.00540350039015","volume":"52","author":"DA Krendel","year":"1995","unstructured":"Krendel DA et al. (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52: 1053\u20131061","journal-title":"Arch Neurol"},{"key":"BFncpendmet0142_CR65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00002512-199507040-00007","volume":"7","author":"C Rains","year":"1995","unstructured":"Rains C and Bryson HM (1995) Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7: 317\u2013328","journal-title":"Drugs Aging"},{"key":"BFncpendmet0142_CR66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ et al. (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109\u2013118","journal-title":"Pain"},{"key":"BFncpendmet0142_CR67","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock J et al. (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110: 628\u2013638","journal-title":"Pain"},{"key":"BFncpendmet0142_CR68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s004150050179","volume":"245","author":"G Said","year":"1998","unstructured":"Said G et al. (1998) Uncommon early-onset neuropathy in diabetic patients. J Neurol 245: 61\u201368","journal-title":"J Neurol"},{"key":"BFncpendmet0142_CR69","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","volume":"50","author":"Y Harati","year":"1998","unstructured":"Harati Y et al. (1998) Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50: 1842\u20131846","journal-title":"Neurology"},{"key":"BFncpendmet0142_CR70","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60: 1524\u20131534","journal-title":"Arch Neurol"},{"key":"BFncpendmet0142_CR71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","volume":"42","author":"S Sindrup","year":"1990","unstructured":"Sindrup S et al. (1990) The selective serotonin reuptake inhibitor paroxetine is effective in treatment of diabetic neuropathy symptoms. Pain 42: 135\u2013144","journal-title":"Pain"},{"key":"BFncpendmet0142_CR72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ et al. (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109\u2013118","journal-title":"Pain"},{"key":"BFncpendmet0142_CR73","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M et al. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280: 1831\u20131836","journal-title":"JAMA"},{"key":"BFncpendmet0142_CR74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007691-199708000-00006","volume":"19","author":"JC DeToledo","year":"1997","unstructured":"DeToledo JC et al. (1997) Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19: 394\u2013396","journal-title":"Ther Drug Monit"},{"key":"BFncpendmet0142_CR75","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","volume":"63","author":"P Raskin","year":"2004","unstructured":"Raskin P et al. (2004) Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63: 865\u2013873","journal-title":"Neurology"},{"key":"BFncpendmet0142_CR76","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1210\/jc.2004-2376","volume":"90","author":"A Vinik","year":"2005","unstructured":"Vinik A (2005) Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90: 4936\u20134945","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0142_CR77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.1992.tb01819.x","volume":"9","author":"PR Cavanagh","year":"1992","unstructured":"Cavanagh PR et al. (1992) Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 9: 469\u2013474","journal-title":"Diabet Med"},{"key":"BFncpendmet0142_CR78","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1532-5415.2004.52200.x","volume":"52","author":"T Liu-Ambrose","year":"2004","unstructured":"Liu-Ambrose T et al. (2004) Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc 52: 657\u2013665","journal-title":"J Am Geriatr Soc"},{"key":"BFncpendmet0142_CR79","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"EB Jude","year":"2001","unstructured":"Jude EB et al. (2001) Biphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomized controlled trial. Diabetologia 44: 2032\u20132037","journal-title":"Diabetologia"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpendmet0142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:48:56Z","timestamp":1684439336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BFncpendmet0142"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0142","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}